NEW YORK (GenomeWeb News) – The Broad Institute said today that it will use Appistry to distribute its Genome Analysis Toolkit (GATK) platform for use by for-profit companies.

Broad said that Appistry will make the GATK 2.0 platform available to for-profit companies under license agreements and subscription fees that are separate from the free arrangements used by non-profit and academic researchers. The subscription fees will cover commercial-grade support for installation, configuration, and documentation, and long-term support for each new release, Broad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."